Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
38results about How to "Improve stool properties" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Bifidobacterium animalis subsp. Lactis i797, purification method and application thereof
ActiveCN111484957AGood for intestinal regulationEnsure balanceMilk preparationBacteriaBiotechnologyLactic acid bacterium
Owner:JUNLEBAO DAIRY GRP CO LTD
Chinese medicine composition, and preparation method and applications thereof
ActiveCN103386110AAvoid bitter smellImprove stool propertiesTea extractionDigestive systemCodonopsisBlack tea
The invention discloses a Chinese medicine composition. The Chinese medicine composition comprises the following raw materials in parts by weight: 3-15 parts of ginseng, 3-15 parts of rhizome zingiberis, 2-10 parts of cortex cinnamomi, 7-35 parts of orange peels, 3-15 parts of rhizome dioscoreae, 5-25 parts of fructus jujubae, 1-20 parts of poria cocos, 1-60 parts of white hyacinth beans, 1-20 parts of citrus chirocarpus, 1-10 parts of semen raphani, 1-120 parts of black tea, 0-150 parts of radix codonopsis, 0-50 parts of American ginseng, 0-50 parts of sweet-scented osmanthus, 0-30 parts of semen myristicae, 0-60 parts of fresh ginger, 0-20 parts of endothelium corneum gigeriae galli, and 0-30 parts of fructus hordei germinatus. The invention further provides a preparation method of the Chinese medicine composition, and applications of the Chinese medicine composition in the fields of medicaments, health-care products, food and the like. The medicaments, health-care products or food are prepared from multiple herbal Chinese medicines which are coordinated in compatibility, take advantages of each other and are safe and effective, so that the good mouthfeel and safety of the products can be guaranteed, the bitter and astringent taste of medicaments can be avoided, and the Chinese medicine composition has the effects of tonifying the spleen, warming up the stomach, and improving the gastrointestinal function.
Owner:中国药材公司
Functional food capable of relaxing bowel and alleviating constipation
InactiveCN107183705AImprove constipationEasy to pushFood ingredient functionsDietary fiberPowder mixture
The invention discloses a functional food capable of relaxing bowel and alleviating constipation. The active ingredients of the functional food comprise 20-40 parts of bunge cherry seed extracts, 20-40 parts of hemp seed extracts, 15-35 parts of dietary fibers, 15-35 parts of aloe extracts and 10-30 parts of cassia seed extracts. The invention further provides a preparation method of the functional food cable of relaxing the bowel and alleviating the constipation. The preparation method comprises the following steps that firstly, the powdered raw materials of all the active ingredients are put into a stirring machine and stirred to be uniform, a powdered mixture is obtained; secondly, the powdered mixture is dried and sterilized; thirdly, the dried and sterilized powdered mixture passes through a 60-100 mesh screen, and then the powdery functional food capable of relaxing the bowel and alleviating the constipation is obtained. All the active ingredients are cooperated and mutually complemented and promoted in scientific proportion, and the powerful and complete functions of relaxing the bowel and alleviating the constipation are brought into play.
Owner:凯泽(武汉)健康管理有限公司
Bifidobacterium animal subspecies lactis JMCC0025 and isolation and purification method and application of JMCC0025
InactiveCN110923166AGood for intestinal regulationEnsure balanceMilk preparationBacteriaBiotechnologyLactic acid bacterium
The invention discloses an Bifidobacterium animal subspecies lactis JMCC0025. The strain of JMCC0025 was deposited in General Microbiology Center of China Microbiological Culture Collection ManagementCommittee on August 20, 2019, the deposit address is No. 3, yard 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is CGMCC NO. 18403; and the invention also discloses a methodof isolation and purification and application of the above Bifidobacterium animal subspecies lactis JMCC0025. The Bifidobacterium animal subspecies lactis JMCC0025 provided by the present invention can regulate intestinal flora balance, improve fecal characteristics, and has better better survival rate of simulated digestive fluid; and under the storage condition of 37 DEG C, which is suitable for the growth of lactic acid bacteria, the post-acid can be well controlled. The invention belongs to the technical field of bioengineering, and the provided Bifidobacterium animal subspecies lactis JMCC0025 has the function of regulating intestinal flora balance, and can be used in the process of making food, medicine or beverage.
Owner:JUNLEBAO DAIRY GRP CO LTD
Application of lactobacillus rhamnosus to preventing and relieving ulcerative colitis
ActiveCN112625964AEasily damagedIncrease richnessMilk preparationBacteriaLactobacillus rhamnosusUlcerative colitis
The invention discloses an application of lactobacillus rhamnosus to preventing and relieving ulcerative colitis, and belongs to the technical field of functional microorganisms. The lactobacillus rhamnosus can tolerate the gastrointestinal environment of a human body, significantly reduce weight loss during the period of ulcerative colitis, improve fecal traits and hematochezia, improve colon mucosal injury, reduce MPO activity, and reduce the content of proinflammatory factors TNF-alpha, IL-1beta, IL-6 and IFN-gamma in colon. The transcription levels of colon close junction related proteins Claudin-3, ZO-1, ZO-2 and Occludin, antibacterial peptides Reg3g and Reg3b and mucoprotein MUC2 are up-regulated, the abundance of short-chain fatty acid producing bacteria Coprococcus and Faecalibacterium and the content of short-chain fatty acid are improved, the abundance of beneficial bacteria Lactobacillus in intestinal tracts is increased, the abundance of the conditional pathogenic bacteria Acinetobacter is reduced, and the abundance and diversity of intestinal flora are increased.
Owner:JIANGNAN UNIV
Chinese herb extract composition for treating functional gastrointestinal disorder or irritable bowel syndrome, preparation method and application of composition to preparation of medicine
ActiveCN103735685AEasy to prepareEnrichment of active ingredientsDigestive systemPlant ingredientsSaposhnikoviaCombined treatment
The invention discloses a Chinese herb extract composition for treating functional gastrointestinal disorder or irritable bowel syndrome, a preparation method and application of the composition to preparation of a medicine. The Chinese herb extract composition comprises the following Chinese medicinal herb extracts in parts by weight: 13-29 parts of langehead atractylodes rhizome extract I, 18-57 parts of langehead atractylodes rhizome extract II, 13-53 parts of radix paeoniae alba extract, 6-32 parts of pericarpium citri reticulatae extract and 2-27 parts of divaricate saposhnikovia root extract, wherein the langehead atractylodes rhizome extract I is an extract of a distillation method or supercritical extraction method; the langehead atractylodes rhizome extract II is a water extract; the radix paeoniae alba extract is an alcohol extract; the pericarpium citri reticulatae extract is an alcohol extract; the divaricate saposhnikovia root extract is an aqueous extract or supercritical extract. According to the Chinese herb extract composition, the conventional view that co-decocting or total extracting of a Chinese herbal compound is superior to respective extracting of each Chinese medicinal herb is overcome, the pharmacological effect is remarkably improved through optimized combined treatment of each Chinese medicinal herb extract, and the quality control of the composition is facilitated. The Chinese herb extract composition for treating functional gastrointestinal disorder or irritable bowel syndrome, disclosed by the invention, has an unexpected effect.
Owner:NANJING XINTONG RUIYI MEDICINE SCI & TECH
Bifidobacterium longum subsp. Longum capable of preventing and relieving colitis symptoms and application thereof
ActiveCN114164134AEasily damagedEasy to changeBacteriaDigestive systemBiotechnologyUlcerative colitis
The invention provides bifidobacterium longum subsp. Longum KLDS K5 capable of preventing and relieving symptoms of colitis, and belongs to the technical field of microorganisms. The invention further provides a preparation method of the bifidobacterium longum subsp. Longum KLDS K5. Experiments show that the bifidobacterium longum provided by the invention can tolerate the human gastrointestinal environment, relieve weight loss in the ulcerative colitis disease period, improve colonic mucosa injury and reduce MPO activity, and inhibit oxidation-related factors through iNOS and COX-2 signal pathways so as to relieve inflammatory bowel diseases; nF-kappa B p65 nuclear transfer is inhibited through a TLR4 / MyD88 / NF-kappa B signal channel, the expression quantity of proinflammatory factors TNF-alpha, IL-1beta, IL-6 and IL-10 in colon is reduced, the transcriptional level of colon tight connection related proteins Claudin-1, ZO-1 and Occludin and mucoprotein MUC2 is up-regulated, the intestinal flora change after DSS induction can be improved in the genus level, and the richness and diversity of the intestinal flora are improved.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY
Food for relaxing bowel
The invention discloses food for relaxing bowel. The food for relaxing the bowel contains 0.5 to 99.9 percent of L-arabinose and is prepared by adopting a conventional method. The peristalsis of stomach and intestines of mice can be promoted by the L-arabinose so as to eliminate a constipation syndrome. By utilizing the natural product, the food for relaxing the bowel has characteristic that the digestion of nutrients such as protein and vitamins are not influenced, so that the advantage on relaxing the bowel is adequately played, and the health purpose for relaxing the bowel can be realized.
Owner:中德瑞生物炼制实验室(厦门)有限公司
Traditional Chinese medicine preparation for relaxing bowel and expelling toxin and preparation method thereof
InactiveCN104013789AIncreased bowel movementsImprove bowel movementsDigestive systemCapsule deliveryDiseaseRadix Ophiopogonis
The invention discloses a traditional Chinese medicine preparation for relaxing bowel and expelling toxin and a preparation method thereof. The traditional Chinese medicine comprises raw materials of an aloe dry powder, polygonum multiflorum, radix astragali and Radix Ophiopogonis. Raw materials includin polygonum multiflorum, radix astragali and Radix Ophiopogonis are leached for power process, the power is blended with the aloe dry powder, and the mixture is filled in capsules. The product is not only safe for administration, but also has significant disease control effect and low industrialized production cost.
Owner:高益槐 +1
Novel milk powder and manufacturing method thereof
PendingCN111345351APromote absorptionPromote digestion and absorptionMilk preparationBiotechnologyBone density
The invention relates to the field of milk powder manufacturing, and in particular to novel milk powder and a manufacturing method thereof. The milk powder comprises the following components in partsby weight: OPO, whey protein powder (containing milk fat globule membranes and cephalin groups), raw milk, yak milk or whole yak milk powder, oligosaccharide, choline, DHA and lutein, and also comprises SN-2, wherein the content of the SN-2 is 60% or above of the weight of total palmitic acid in the milk powder. The OPO structural fat used in the novel milk powder is a new generation OPO, and thenovel milk powder has SN-2 close to the SN-2 level of breast milk, is beneficial to digestion and absorption of babies, and can improve energy intake, reduce constipation, enhance bone density, increase intestinal tract probiotics, reduce crying and improve night sleep. The novel milk powder can also improve cognitive ability, learning ability and memory of infants, can promote growth of probiotics, enhance the immune function of intestinal tracts, improve the stool character of the infants, reduce occurrence of constipation, and promote absorption and utilization of various nutrient substances.
Owner:临夏州燎原乳业有限公司
Lactobacillus rhamnosus capable of preventing and relieving ulcerative colitis and application of lactobacillus rhamnosus
ActiveCN112481175AImprove stool propertiesGood conditionBacteriaDigestive systemLactobacillus rhamnosusUlcerative colitis
The invention discloses lactobacillus rhamnosus capable of preventing and relieving ulcerative colitis and application of the lactobacillus rhamnosus, and belongs to the technical field of functionalmicroorganisms. Lactobacillus rhamnosus CCFM1128 can tolerate the gastrointestinal environment of a human body, remarkably improve weight loss during ulcerative colitis, improve fecal traits and hematochezia conditions, reduce colon mucosal injury, reduce MPO activity, reduce generation of proinflammatory factors TNF-alpha, IL-1beta, IL-6 and IFN-gamma in colon, reduce the content of proinflammatory factors IL-6 in serum, up-regulate the gene transcription level of colon close connection related proteins Claudin-3, ZO-1, ZO-2 and Occludin, up-regulate the transcription level of antibacterial peptide CRAMP in the colon, increase the content of short-chain fatty acid in excrement, improve the diversity of intestinal flora, and improve the abundance of short-chain fatty acid producing bacteria Coprococcus in the intestinal tract.
Owner:JIANGNAN UNIV
Application of a strain of Lactobacillus rhamnosus in preventing and relieving ulcerative colitis
ActiveCN112625964BEasily damagedIncrease richnessMilk preparationBacteriaInflammatory factorsLactobacillus rhamnosus
The invention discloses the application of a strain of Lactobacillus rhamnosus in preventing and relieving ulcerative colitis, and belongs to the technical field of functional microorganisms. Lactobacillus rhamnosus can tolerate the human gastrointestinal environment, significantly reduce weight loss during ulcerative colitis, improve stool texture and blood in the stool, improve colonic mucosal damage, reduce MPO activity, and reduce the pro-inflammatory factor TNF-α in the colon , IL-1β, IL-6, IFN-γ content, up-regulate the transcription levels of colon tight junction-related proteins Claudin-3, ZO-1, ZO-2 and Occludin, antimicrobial peptides Reg3g, Reg3b and mucin MUC2, increase the transcription level of short chain The abundance of fatty acid-producing bacteria Coprococcus, Faecalibacterium and the content of short-chain fatty acids increased the abundance of beneficial bacteria Lactobacillus and decreased the abundance of opportunistic pathogen Acinetobacter, increasing the richness and diversity of intestinal flora.
Owner:JIANGNAN UNIV
Health care composition for relaxing bowels and improving organism immunity and preparation method
InactiveCN103027963AEasy to operateLow costOrganic active ingredientsDigestive systemBiological bodySugar
The invention discloses a health care composition, an oral liquid and a health care product for relaxing bowels and improving organism immunity, and a preparation method of the health care composition, the oral liquid and the health care product. The composition is prepared by mixing extractives extracted from semen cassiae, polygonum multiflorum and gynostemma pentaphyllum by enthanol with fructooligosaccharide; a sugar aspartame sweetener and a citric acid additive are added to the prepared health care composition and filled to be prepared into the oral liquid; corresponding pharmaceutical necessities can also be added to be prepared into a capsule or troche, the health care composition, the oral liquid and the health care product have functions of relaxing the bowels and improving the organism immunity, and have no adverse reactions to body health, and the preparation method of the health care composition, the oral liquid and the health care product is simple; no additional cost exists; and the method can be widely used for industrial production.
Owner:湖南省强生药业有限公司
Chinese medicine composition, and preparation method and applications thereof
ActiveCN103386110BAvoid bitter smellImprove stool propertiesTea extractionDigestive systemBiotechnologyWolfiporia extensa
Owner:中国药材公司
Application of peimine in preparation of medicine for preventing and/or treating ulcerative colitis
InactiveCN113143939AEnsure safetyNo obvious pathological symptomsOrganic active ingredientsAntipyreticLaboratory mouseUlcerative colitis
The invention discloses application of peimine in preparation of a medicine for preventing and / or treating ulcerative colitis, and relates to the field of medicines. According to the invention, experiments prove that the peimine has no significant influence on experimental mice: the experimental mice of a peimine group have no death; the weight has no significant change; the intestinal tissue has no obvious lesion; the colon and the cecum have no obvious pathological symptoms; and the peimine has certain safety. The peimine can reduce the weight loss rate of a mouse with the ulcerative colitis, can improve the fecal character and hemafecia condition of the mouse with the ulcerative colitis, can improve DAI of the mouse with the ulcerative colitis, and can effectively prevent and improve pathological damage of intestinal tissues of the mouse with the ulcerative colitis; therefore, the peimine has particularly excellent ulcerative colitis resisting activity and certain safety, and can obviously improve the ulcerative colitis symptom.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE +1
Application of peimisine in preparation of medicine for preventing and/or treating ulcerative colitis
PendingCN113288902AReduce weight lossImprove stool texture and bloody stoolOrganic active ingredientsDigestive systemLesionPharmacology
The invention discloses application of peimisine in preparation of medicines for preventing and / or treating ulcerative colitis, and relates to the field of medicines. Experiments prove that the peimisine has no significant influence on experimental mice: the experimental mice in a peimisine group have no death, no significant change in body weight, no obvious lesion in intestinal tissues, no obvious pathological symptoms in colon and cecum, and the peimisine has certain safety. The peimisine can reduce the weight loss rate of a mouse with the ulcerative colitis, can improve the fecal character and hemafecia condition of the mouse with the ulcerative colitis, can improve DAI of the mouse with the ulcerative colitis, and can effectively prevent and improve pathological damage of intestinal tissues of the mouse with the ulcerative colitis; and therefore, the peimisine has particularly excellent anti-ulcerative colitis activity and certain safety, and can obviously improve the ulcerative colitis symptom.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE +1
Traditional Chinese medicine composition for treating qi stagnation type post-PPH (procedure for prolapse and hemorrhoids) constipation
InactiveCN105327010AReduce congestionCompatibility is reasonableDigestive systemPlant ingredientsCheiranthusTraditional medicine
The invention belongs to the technical field of medicine, in particular to a traditional Chinese medicine composition for treating qi stagnation type post-PPH (procedure for prolapse and hemorrhoids) constipation. The composition comprises following herbs by weight: Lithocarpus dealbatus inflorescence 4-8 parts, Caulis Perillae Furtescentis 4-8 parts, Herba Andrographitis Laxiflorae 5-13 parts, Folium Perillae Frutesentis 4-8 parts, Herba Gerberae Piloselloidis 4-8 parts, Radix Gmelinae Delauayanae 4-8 parts, Fructus Citri Grandis 4-8 parts, Herba Doronici Altaici 4-8 parts, Flos Cheiranthus 4-8 parts, Fructus Bothocaryum 4-8 parts, and Radix Glycyrrhizae 4-8 parts. The herbs are jointly effective in facilitating lung and promoting qi circulation and loosening the bowel to relieve constipation, are safe and effective in treating qi stagnation type post-PPH constipation, and can significantly improve stool property and relive constipation symptoms such as anal obstructive feeling, laborious defecation, tenesmus and defecation pain.
Owner:JINAN BANGWEN MEDICAL TECH
Traditional Chinese medicine composition granule for treating gastrointestinal diseases and preparation method thereof
ActiveCN101757292AGood treatment effectImprove clinical symptomsOrganic active ingredientsDigestive systemAdemetionineLigusticum chuanxiong
The invention relates to a traditional Chinese medicine composition granule for treating gastrointestinal diseases and a preparation method thereof. The traditional Chinese medicine composition granule is prepared from tens of traditional Chinese herbs of costustoot, agilawood, fructus aurantii, sanders, rheum officinale, mangnolia officinalis, muak, defatted croton seed powder, date and ligusticum wallichii. The traditional Chinese medicine composition granule is mainly used for treating diseases of acute diarrhea, irritable bowel syndrome and the like in clinic.
Owner:津药达仁堂集团股份有限公司乐仁堂制药厂
Composition for treating ulcerative colitis as well as granules and preparation method thereof
InactiveCN109512884AAppropriate tasteNo lossDigestive systemPharmaceutical non-active ingredientsSide effectSucrose
The invention belongs to the technical field of drug preparations, and particularly relates to a composition for treating uclerative colitis as well as granules and a preparation method thereof. The composition is prepared from the following components in parts by weight: 5-12 parts of radix scutellariae, 1-5 parts of rhizoma coptidis, 5-10 parts of cortex phellodendri and 4-10 parts of treated folium artemisiae argyi. The granules are prepared from the following raw materials in parts by weight: 15-37 parts of the composition for treating ulcerative colitis, 0.5-2 parts of a sweetening agent,0.5-2 parts of micro powder silica gel, 1-3 parts of sucrose fatty acid ester, 0.5-1.5 parts of crospolyvinyl pyrrolidone and 3-6 parts of microcrystalline cellulose. The composition for treating ulcerative colitis has an outstanding treatment effect on ulcerative colitis; meanwhile, the granules prepared by applying the composition have good stability, are uniformly dispersed after being dissolved in water, has good taste and low toxic and side effects, and is suitable for being applied and popularized.
Owner:GUANGDONG PHARMA UNIV +1
Application of molybdenum-based polyoxometallate cluster in treatment of inflammatory diseases
ActiveCN114469992AImprove stool propertiesRelief of clinical symptomsHeavy metal active ingredientsAntipyreticPolyoxometalate IDisease
The invention discloses an application of a molybdenum-based polyoxometallate cluster in treatment of inflammatory diseases. The inflammatory disease is related to the rising of the ROS level. Experiments show that the molybdenum-based polyoxometallate cluster achieves the purpose of preventing or treating inflammatory diseases by reducing the ROS level in tissues. Therefore, the molybdenum-based polyoxometallate cluster can be used for preparing the medicine for treating the inflammatory diseases, the application of the molybdenum-based polyoxometallate cluster is widened, the new medicine for treating the inflammatory diseases is developed, an experimental basis is provided for treating clinical inflammatory diseases by the molybdenum-based polyoxometallate cluster, and the molybdenum-based polyoxometallate cluster has a good application prospect. The invention also provides a medicine for treating inflammatory diseases. The medicine for treating the inflammatory diseases can be used for effectively treating the inflammatory diseases.
Owner:THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
Composition with health-care function and preparation method and application thereof
The invention provides a composition with health-care function and a preparation method and application thereof. The composition mainly comprises 1 to 150g / kg of fructooligosaccharide and 0.18 to 73g / kg of chlorogenic acid; and the composition is mainly prepared by the steps of chlorogenic acid extraction, fructooligosaccharide extraction, blending, processing and shaping and the like. The composition can be directly used as a raw material of food, food additive and health-care food, and has good curative effects of moistening the intestines and freeing the stool, conditioning the gastrointestinal tract, assisting treatment or preventing diabetes; and the composition is prepared into various forms easy for administration of the public, the product administrated by the public is safe and simple and has no bad stimulation on the gastrointestinal tract or side effect, and the production process is simple, feasible and easy for popularization.
Owner:贵阳高新创嘉创业服务有限公司
Traditional Chinese medicine composition for treating yin-fluid and blood deficiency type constipation after PPH (procedure for prolapse and hemorrhoids) for treatment of hemorrhoidal disease
InactiveCN105168728AReduce congestionRelieves strained bowel movementsDigestive systemPlant ingredientsFicus esquirolianaTraditional medicine
The invention belongs to the technical field of medicines, and particularly relates to traditional Chinese medicine composition for treating yin-fluid and blood deficiency type constipation after a PPH (procedure for prolapse and hemorrhoids) for treatment of a hemorrhoidal disease. The traditional Chinese medicine composition comprises traditional Chinese medicines in parts by weight as follows: 4-8 parts of all-grass of intermediate peashrub, 4-8 parts of mulberry fruits, 4-8 parts of rugosa paraphlomis, 4-8 parts of Fimbristylis rigiduta Nees, 4-8 parts of Linum stellarioides Planch., 4-8 parts of ficus esquiroliana,4-8 parts of roots of bilobed grewia, 5-13 parts of andrographis tenera (Nees) O.Kuntze, 4-8 parts of leaves of common perilla, 4-8 parts of herb of pilose gerbera, 4-8 parts of gmelina delavayana P. Dop, 4-8 parts of immature fruits of Pummelo, 4-8 parts of doronicum altaicum pallas, 4-8 parts of siberian wallflower, 4-8 parts of bothrocaryum controuersa (Hemsl.) Poyark. and 4-8 parts of liquorice. The traditional Chinese medicines are combined to perform the efficacy of lung ventilating, promotion of qi circulation, yin and blood nourishment, promotion of feces excretion and stagnation removal, and the traditional Chinese medicine composition is safe and effective in treatment of yin-fluid and blood deficiency type constipation after the PPH for treatment of the hemorrhoidal disease and can remarkably improve the stool property and relieve the blocking feeling of the anus, feeling of labored defecation, tenesmus, pain during defecation and other constipation symptoms.
Owner:JINAN BANGWEN MEDICAL TECH
Traditional Chinese medicine composition for treatment of heat-in-stomach type hemorrhoidal PPH (procedure for prolapse and hemorrhoids) postoperative constipation
InactiveCN105232700AReduce congestionRelieves strained bowel movementsDigestive systemPlant ingredientsBothrocaryum controversumPerilla frutescens leaf
The invention belongs to the technical field of medicines and particularly relates to a traditional Chinese medicine composition for treatment of heat-in-stomach type hemorrhoidal PPH (procedure for prolapse and hemorrhoids) postoperative constipation. The traditional Chinese medicine composition is composed of, by weight, 4-8 parts of rhamnus parvifolia, 4-8 parts of rhamnus davurica pall, 5-13 parts of andrographis laxiflora, 4-8 parts of perilla frutescens leaf, 4-8 parts of herba gerberae piloselloidis, 4-8 parts of berberis anhweiensis ahrendt, 4-8 parts of rumex gmelini, 4-8 parts of doronicum altaicum, 4-8 parts of cheiranthus cheiri, 4-8 parts of fruit of bothrocaryum controversum, 4-8 parts of immature fruit of pummel and 4-8 parts of radix glycyrrhiza. By joint use of crude medicines, efficacies of lung ventilating, Qi promoting, heat purging, stasis removing and bowel relaxing are achieved, safety and effectiveness in treatment of heat-in-stomach type hemorrhoidal PPH postoperative constipation are realized, stool character can be evidently improved, and constipation symptoms such as anal blockage feeling, defection strenuous feeling, tenesmus feeling, defection aching feeling and the like are alleviated.
Owner:JINAN BANGWEN MEDICAL TECH
Pharmaceutical composition for preventing and/or treating diarrhea-type irritable bowel syndrome and its preparation method and application
ActiveCN111346193BImprove clinical symptomsReduce abdominal painDispersion deliveryDigestive systemEfficacyPharmaceutical drug
Owner:JIANGSU KANION PHARMA CO LTD
Chrysanthemum stem and leaf multi-component granule capable of improving intestinal function, its preparation method and application
ActiveCN110101732BIncrease contentImprove living conditionsDigestive systemPharmaceutical non-active ingredientsBiotechnologyNutritive values
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Pharmaceutical composition capable of preventing and/or treating Diarrhea Predominant Irritable Bowel Syndrome (IBS-D), and preparation method and application thereof
ActiveCN111346193AReduce diarrheaRelieve abdominal pain and other symptoms of abdominal discomfortDispersion deliveryDigestive systemEfficacyPharmaceutical drug
The invention relates to a pharmaceutical component capable of preventing and / or treating Diarrhea Predominant Irritable Bowel Syndrome (IBS-D), and a preparation method and an application thereof. The pharmaceutical component contains roasted radix astragali, fried bighead atractylodes rhizome, radix paeoniae alba, rhizoma corydalis, fructus alpiniae oxyphyllae, fried gordon euryale, finger citron, fried cortex ailanthi and nutmegs. The pharmaceutical component has the following effects: (1) improving clinical symptoms of a patient significantly; (2) relieving an abdominal pain degree of thepatient and improving properties of stool of the patient effectively; (3) improving life quality of the patient obviously; (4) reducing a serum 5-HT level of the patient obviously; and (5) being low in recurrence rate.
Owner:JIANGSU KANION PHARMA CO LTD
Traditional Chinese medicine composition for treating qi and yang deficiency type constipation after hemorrhoids PPH (Procedure for Prolapse and Hemorrhoids) surgery
InactiveCN105125691AReduce congestionRelieves strained bowel movementsDigestive systemPlant ingredientsFicus esquirolianaCornus controversa
The invention belongs to the technical field of medicaments, and particularly relates to a traditional Chinese medicine composition for treating qi and yang deficiency type constipation after a hemorrhoids PPH (Procedure for Prolapse and Hemorrhoids) surgery. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicaments in parts by weight: 4 to 8 parts of Juglans mandshurica Maxim nuts, 4 to 8 parts of walnut oil, 4 to 8 parts of Ficus esquiroliana, 4 to 8 parts of root of bilobed grewia, 5 to 13 parts of Andrographis laxiflora, 4 to 8 parts of white perilla leaf, 4 to 8 parts of herba gerberae piloselloidis, 4 to 8 parts of Pimpinella coriacea, 4 to 8 parts of piper sarmentosum, 4 to 8 parts of Gmelina delavayana, 4 to 8 parts of immature fruit of Pummelo, 4 to 8 parts of Doronicum altaicum Pallas, 4 to 8 parts of English wallflower, 4 to 8 parts of Cornus controversa fruits and 4 to 8 parts of Glycyrrhiza uralensis. The traditional Chinese medicine composition has the effects of diffusing the lung and promoting the circulation of qi, invigorating qi and warming yang, relaxing the bowels and removing stagnancy after combined use of all the medicinal materials, is safe and effective to treat the constipation (qi and yang deficiency type) after the PPH surgery, and can be used for remarkably improving the stool property and alleviating the constipation symptoms, such as blockage sense of anus, strenuosity sense of defecation, tenesmus sense, defecation pain sense and the like.
Owner:JINAN BANGWEN MEDICAL TECH
Application of sipeimine in preparation of medicines for preventing and/or treating ulcerative colitis
InactiveCN113209095AEnsure safetyNo obvious lesionsOrganic active ingredientsDigestive systemLaboratory mouseUlcerative colitis
The invention discloses application of sipeimine in preparation of medicines for preventing and / or treating ulcerative colitis, and relates to the field of medicines. According to the invention, experiments prove that the sipeimine does not cause significant influence on experimental mice: there is no death, no significant change in body weight, no obvious lesion in intestinal tissues and no obvious pathological symptoms in colon and cecum for the experimental mice in a sipeimine group, showing that the sipeimine has certain safety. The sipeimine can reduce the weight loss rate of mice with ulcerative colitis, improve the fecal character and the hemafecia condition of the mice with ulcerative colitis, improve DAI of the mice with ulcerative colitis and effectively prevent and improve pathological damage of intestinal tissues of the mice with ulcerative colitis, suggesting that the sipeimine has particularly excellent anti-ulcerative colitis activity and certain safety, and can obviously improve ulcerative colitis symptoms.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE +1
Traditional Chinese medicine composition for treating yin-coldness stagnation type constipation after PPH (procedure for prolapse and hemorrhoids) for treatment of hemorrhoidal disease
InactiveCN105169171AReduce congestionRelieves strained bowel movementsDigestive systemPlant ingredientsGmelinaFeces
The invention belongs to the technical field of medicines, and particularly relates to traditional Chinese medicine composition for treating yin-coldness stagnation type constipation after a PPH (procedure for prolapse and hemorrhoids) for treatment of a hemorrhoidal disease. The traditional Chinese medicine composition comprises traditional Chinese medicines in parts by weight as follows: 4-8 parts of hedychium spicatum, 4-8 parts of fruit of zollinger gromwell, 5-13 parts of andrographis tenera (Nees) O.Kuntze, 4-8 parts of leaves of common perilla, 4-8 parts of herb of pilose gerbera, 4-8 parts of pimpinella coriacea, 4-8 parts of piper sarmentosum roxb., 4-8 parts of roots of gmelina delavayana P. Dop, 4-8 parts of immature fruits of Pummelo, 4-8 parts of doronicum altaicum pallas, 4-8 parts of siberian wallflower, 4-8 parts of bothrocaryum controuersa (Hemsl.) Poyark. and 4-8 parts of liquorice. The traditional Chinese medicines are combined to perform efficacy of lung ventilating, promotion of qi circulation, interior warming, coldness dispelling, promotion of feces excretion and stagnation removal, and the traditional Chinese medicine composition is safe and effective when used for treating yin-coldness stagnation type constipation after the PPH (procedure for prolapse and hemorrhoids) for treatment of the hemorrhoidal disease and can remarkably improve the stool property and relieve the blocking feeling of the anus, feeling of labored defecation, tenesmus, pain during defecation and other constipation symptoms.
Owner:JINAN BANGWEN MEDICAL TECH
Health care composition for relaxing bowels and improving organism immunity and preparation method
InactiveCN103027963BWeakened immunityEnhanced delayed-type hypersensitivityOrganic active ingredientsDigestive systemBiological bodySugar
Owner:湖南省强生药业有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com